Brainstorm Cell Therapeutics (BCLI) Shares Outstanding (2010 - 2026)
Brainstorm Cell Therapeutics (BCLI) reported Shares Outstanding of 11.03 million for Q2 2026, up 28.0% from 8.62 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Brainstorm Cell Therapeutics (BCLI) Shares Outstanding (2010 - 2026) Analysis & Trends
For FY2025, Brainstorm Cell Therapeutics posted Shares Outstanding of 9.27 million, up 84.6% from FY2024.
- Shares Outstanding has increased for 15 consecutive years, with a five-year compound annual growth rate of 36.0% (FY2020 to FY2025).
- By year, Shares Outstanding came in at 5.02 million in FY2024 (+74.9%), 2.87 million in FY2023 (+18.0%), 2.43 million in FY2022 (+0.9%) and 2.41 million in FY2021 (+21.2%).
- Year over year, Shares Outstanding has now increased in each of the last 61 quarters, with growth averaging 72.2% over the last eight quarters.
- Across the past five years, year-over-year growth in Shares Outstanding ran from 0.5% in Q2 2022 to 107.3% in Q3 2025.
- Per Business Quant data, the three quarters before Q2 2026 came in at 11.03 million (Q1 2026), 9.27 million (Q4 2025) and 11.01 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,163.48 Bn | 1,132.06 Bn | 19.71 Bn | 892.40 Mn |
| 2 | Johnson & Johnson | 631.16 Bn | 549.69 Bn | 17.26 Bn | 2.41 Bn |
| 3 | AbbVie | 502.63 Bn | 475.74 Bn | 12.70 Bn | 1.77 Bn |
| 4 | Merck | 378.53 Bn | 332.91 Bn | 12.21 Bn | 2.47 Bn |
| 5 | Novartis Ag | 302.83 Bn | 266.82 Bn | 11.24 Bn | 1.94 Bn |
| 6 | Astrazeneca | 265.92 Bn | 239.60 Bn | 12.86 Bn | 1.55 Bn |
| 7 | Amgen | 240.87 Bn | 196.27 Bn | 7.24 Bn | 540.00 Mn |
| 8 | Gilead Sciences | 194.04 Bn | 168.24 Bn | 6.22 Bn | 1.24 Bn |
| 9 | Pfizer | 172.14 Bn | 118.78 Bn | 10.94 Bn | 5.70 Bn |
| 10 | Brainstorm Cell Therapeutics | 8.72 Mn | 8.65 Mn | - | 11.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.03 Mn |
| Mar 31, 2026 | 11.03 Mn |
| Dec 31, 2025 | 9.27 Mn |
| Sep 30, 2025 | 11.01 Mn |
| Jun 30, 2025 | 8.62 Mn |
| Mar 31, 2025 | 6.34 Mn |
| Dec 31, 2024 | 5.02 Mn |
| Sep 30, 2024 | 5.31 Mn |
| Jun 30, 2024 | 4.75 Mn |
| Mar 31, 2024 | 4.32 Mn |
| Dec 31, 2023 | 2.87 Mn |
| Sep 30, 2023 | 2.95 Mn |
| Jun 30, 2023 | 2.65 Mn |
| Mar 31, 2023 | 2.45 Mn |
| Dec 31, 2022 | 2.43 Mn |
| Sep 30, 2022 | 2.43 Mn |
| Jun 30, 2022 | 2.43 Mn |
| Mar 31, 2022 | 2.43 Mn |
| Dec 31, 2021 | 2.41 Mn |
| Sep 30, 2021 | 2.42 Mn |
API Access
Brainstorm Cell Therapeutics Shares Outstanding API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding&ticker=BCLI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding", "ticker": "BCLI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding&ticker=BCLI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();